Lisa M. Giles - Net Worth and Insider Trading

Lisa M. Giles Net Worth

The estimated net worth of Lisa M. Giles is at least $529,673 dollars as of 2024-06-09. Lisa M. Giles is the Director of GenMark Diagnostics Inc and owns about 22,033 shares of GenMark Diagnostics Inc (GNMK) stock worth over $529,673. Details can be seen in Lisa M. Giles's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lisa M. Giles has not made any transactions after 2016-08-12 and currently still holds the listed stock(s).

Transaction Summary of Lisa M. Giles

To

Lisa M. Giles Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lisa M. Giles owns 3 companies in total, including Milestone Pharmaceuticals Inc (MIST) , GenMark Diagnostics Inc (GNMK) , and HCW Biologics Inc (HCWB) .

Click here to see the complete history of Lisa M. Giles’s form 4 insider trades.

Insider Ownership Summary of Lisa M. Giles

Ticker Comapny Transaction Date Type of Owner
MIST Milestone Pharmaceuticals Inc 2020-10-01 director
GNMK GenMark Diagnostics Inc 2020-05-29 director
HCWB HCW Biologics Inc 2021-10-26 director

Lisa M. Giles Latest Holdings Summary

Lisa M. Giles currently owns a total of 1 stock. Lisa M. Giles owns 22,033 shares of GenMark Diagnostics Inc (GNMK) as of August 12, 2016, with a value of $529,673.

Latest Holdings of Lisa M. Giles

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GNMK GenMark Diagnostics Inc 2016-08-12 22,033 24.04 529,673

Holding Weightings of Lisa M. Giles


Lisa M. Giles Form 4 Trading Tracker

According to the SEC Form 4 filings, Lisa M. Giles has made a total of 0 transactions in GenMark Diagnostics Inc (GNMK) over the past 5 years. The most-recent trade in GenMark Diagnostics Inc is the acquisition of 823 shares on August 12, 2016, which cost Lisa M. Giles around $7,736.

Insider Trading History of Lisa M. Giles

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lisa M. Giles Trading Performance

GuruFocus tracks the stock performance after each of Lisa M. Giles's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lisa M. Giles is 15.98%. GuruFocus also compares Lisa M. Giles's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lisa M. Giles within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lisa M. Giles's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lisa M. Giles

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 0.74 LIMIT LIMIT LIMIT LIMIT LIMIT

Lisa M. Giles Ownership Network

Ownership Network List of Lisa M. Giles

No Data

Ownership Network Relation of Lisa M. Giles

Insider Network Chart

Lisa M. Giles Owned Company Details

What does Milestone Pharmaceuticals Inc do?

Who are the key executives at Milestone Pharmaceuticals Inc?

Lisa M. Giles is the director of Milestone Pharmaceuticals Inc. Other key executives at Milestone Pharmaceuticals Inc include Chief Medical Officer David Bharucha , 10 percent owner Roderick Wong , and 10 percent owner Rtw Investments, Lp .

Milestone Pharmaceuticals Inc (MIST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Milestone Pharmaceuticals Inc (MIST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Milestone Pharmaceuticals Inc (MIST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Milestone Pharmaceuticals Inc (MIST)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Milestone Pharmaceuticals Inc Insider Transactions

No Available Data

Lisa M. Giles Mailing Address

Above is the net worth, insider trading, and ownership report for Lisa M. Giles. You might contact Lisa M. Giles via mailing address: Durata Therapeutics, Inc., 200 South Wacker Drive Suite 2550, Chicago Il 60606.

Discussions on Lisa M. Giles

No discussions yet.